2021
DOI: 10.52667/2712-9179-2021-1-2-2-20
|View full text |Cite
|
Sign up to set email alerts
|

Juvenile myoclonic epilepsy: current state of the problem

Abstract: Due to the high prevalence of the disease, its genetic and clinical heterogeneity, the need for lifelong therapy and the emergence of new views on the pathogenesis and course of JME, it is necessary to provide primary care physicians (general practitioners, district therapists, neurologists) with up-to-date systematized information about the most common form of genetic generalized epilepsy (Herpin-Janz syndrome). JME is a genetically determined disease of the brain, accompanied by a triad of seizures (absences… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 59 publications
0
1
0
Order By: Relevance
“…First-line treatment refers to the initial AED prescribed, while second-line treatment refers to alternative AEDs used if the first-line treatment fails. JME is a specific type of epilepsy that typically begins during adolescence and is characterized by myoclonic jerks, generalized tonic-clonic seizures, and absence seizures [45].…”
mentioning
confidence: 99%
“…First-line treatment refers to the initial AED prescribed, while second-line treatment refers to alternative AEDs used if the first-line treatment fails. JME is a specific type of epilepsy that typically begins during adolescence and is characterized by myoclonic jerks, generalized tonic-clonic seizures, and absence seizures [45].…”
mentioning
confidence: 99%